Insulin hypersensitivity reactions in type 1 diabetes can be severe and are associated
with significant short- and long-term morbidity.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Canadian Journal of DiabetesAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Insulin allergy.Clin Dermatol. 2011; 29: 300-305
- Hybrid insulin cocrystals for controlled release delivery.Nat Biotechnol. 2002; 20: 800-804
- Insulin allergy: Clinical manifestations and management strategies.Allergy. 2008; 63: 148-155
- A case of insulin-induced localized lobular panniculitis with evidence for the phagocytosis of insulin by histiocytes.Endocr J. 2007; 54: 477-480
- Failure of multiple therapies in the treatment of a type 1 diabetic patient with insulin allergy: A case report.Endocr Pract. 2011; 17: 91-94
- Hypersensitivity reactions to insulins.in: Adkinson N.F. Nathan D.M. UpToDate. 2021https://www.uptodate.com/contents/hypersensitivity-reactions-to-insulinsDate accessed: July 21, 2022
- Clinical pancreatic islet transplantation.Nat Rev Endocrinol. 2017; 13: 268-277
- Continuous intraperitoneal insulin infusion: An alternative route for insulin delivery in type 1 diabetes.Acta Diabetol. 2020; 57: 101-104
- Intraperitoneal insulin therapy for a patient with type 1 diabetes with insulin injection site inflammation.BMJ Case Rep. 2014; 2014bcr201405278
- Continuous intraperitoneal insulin infusion---a valuable option when subcutaneous insulin delivery fails.https://www.accu-chek.de/de/diaport/pdf/160719_accu-chek_diaport_hcp_brochure_final.pdfDate accessed: April 25, 2022
- Physiological effects of intraperitoneal versus subcutaneous insulin infusion in patients with diabetes mellitus type 1: A systematic review and meta-analysis.PLoS One. 2021; 16e0249611
- Drug allergy.Allergy Asthma Clin Immunol. 2018; 14: 60
- New design of a percutaneous port system for continuous intraperitoneal insulin infusion.J Diabetes Sci Technol. 2019; 13: 1158-1160
Article info
Publication history
Published online: August 29, 2022
Accepted:
August 23,
2022
Received in revised form:
July 28,
2022
Received:
June 2,
2022
Identification
Copyright
© 2022 Canadian Diabetes Association.
